NOVOLIN GE TORONTO PENFILL DIN 02024284
Status: Cancelled Post Market
Holder: NOVO NORDISK CANADA INC
Molecule: INSULIN INJECTION HUMAN BIOSYNTHETIC
Available to quote
Health Canada record
| Active ingredient(s) | INSULIN INJECTION HUMAN BIOSYNTHETIC 100 UNIT |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Intravenous; Subcutaneous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | A10AB01 INSULIN (HUMAN) |
| Original market date | 31-Dec-1993 |
| Current status date | 20-Mar-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Novo Nordisk Canada Inc — licence 100175, currently licensed, last inspection rating C (2023-02-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing INSULIN INJECTION HUMAN BIOSYNTHETIC
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02466864 | ENTUZITY KWIKPEN | ELI LILLY CANADA INC | Solution | INSULIN INJECTION HUMAN BIOSYNTHETIC 500 UNIT | Marketed |
| 01959212 | HUMULIN 30/70 CARTRIDGE | ELI LILLY CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 30 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 70 UNIT | Marketed |
| 01959220 | HUMULIN R CARTRIDGE | ELI LILLY CANADA INC | Solution | INSULIN INJECTION HUMAN BIOSYNTHETIC 100 UNIT | Marketed |
| 02024217 | NOVOLIN GE 30/70 | NOVO NORDISK CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 30 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 70 UNIT | Marketed |
| 02024233 | NOVOLIN GE TORONTO | NOVO NORDISK CANADA INC | Solution | INSULIN INJECTION HUMAN BIOSYNTHETIC 100 UNIT | Marketed |
| 01962639 | HUMULIN 10/90 CARTRIDGE | ELI LILLY CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 10 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 90 UNIT | Cancelled Post Market |
| 00889113 | HUMULIN 10/90 INJ | ELI LILLY CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 10 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 90 UNIT | Cancelled Post Market |
| 01962655 | HUMULIN 20/80 CARTRIDGE | ELI LILLY CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 20 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 80 UNIT | Cancelled Post Market |
| 00889105 | HUMULIN 20/80 INJ | ELI LILLY CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 20 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 80 UNIT | Cancelled Post Market |
| 01962647 | HUMULIN 40/60 CARTRIDGE | ELI LILLY CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 40 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 60 UNIT | Cancelled Post Market |
| 00889091 | HUMULIN 40/60 INJ | ELI LILLY CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 40 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 60 UNIT | Cancelled Post Market |
| 01962663 | HUMULIN 50/50 CARTRIDGE | ELI LILLY CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 50 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 50 UNIT | Cancelled Post Market |
| 00889121 | HUMULIN 50/50 INJ | ELI LILLY CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 50 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 50 UNIT | Cancelled Post Market |
| 02024292 | NOVOLIN GE 10/90 PENFILL INJ SUS | NOVO NORDISK A/S | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 10 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 90 UNIT | Cancelled Post Market |
| 02024306 | NOVOLIN GE 20/80 PENFILL INJ SUS | NOVO NORDISK A/S | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 20 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 80 UNIT | Cancelled Post Market |
| 02025248 | NOVOLIN GE 30/70 PENFILL | NOVO NORDISK CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 30 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 70 UNIT | Cancelled Post Market |
| 02024314 | NOVOLIN GE 40/60 PENFILL | NOVO NORDISK CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 40 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 60 UNIT | Cancelled Post Market |
| 02024322 | NOVOLIN GE 50/50 PENFILL | NOVO NORDISK CANADA INC | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 50 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 50 UNIT | Cancelled Post Market |
| 02024446 | NOVOLINSET GE 30/70 INJ SUS | NOVO NORDISK A/S | Suspension | INSULIN INJECTION HUMAN BIOSYNTHETIC 30 UNIT; INSULIN ISOPHANE HUMAN BIOSYNTHETIC 70 UNIT | Cancelled Post Market |
| 02025256 | NOVOLINSET GE TORONTO INJ LIQ 100U/ML | NOVO NORDISK A/S | Liquid | INSULIN INJECTION HUMAN BIOSYNTHETIC 100 UNIT | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 12020 | 2011-01-07 | New Drug Submission (NDS) | Manufacturer name change |
| 5682 | 1994-07-19 | Supplement to a New Drug Submission (SNDS) | NEW PACKAGE SIZE, REVISED PRODUCT MONOGRAPH |